Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-26 · accession 0001415889-25-009193 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-28 | 2025-03-26 | WGS | Stueland Katherine | CEO, Dir | S - Sale+OE | $95.62 | -46.6K | 48.3K | -49% | -$4.45M |
| D | 2025-03-28 | 2025-03-26 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +80.0K | 94.9K | +538% | $0 |
| D | 2025-03-28 | 2025-03-26 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | -80.0K | 240.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-26 | S | D | 44,801 | $95.66 | 50,064 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-03-26 | S | D | 1,750 | $94.59 | 48,314 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-03-26 | M | A | 80,000 | $0.00 | 94,865 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 4 | Derivative | Restricted Stock Unit | 2025-03-26 | M | D | 80,000 | $0.00 | 240,000 | D | — · — to — | 80,000 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 25% of the underlying restricted stock units each vests annually, commencing on March 26, 2025, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |